| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.82 |
| 52 Week High | CN¥13.88 |
| 52 Week Low | CN¥6.90 |
| Beta | 0.15 |
| 1 Month Change | -10.24% |
| 3 Month Change | 4.47% |
| 1 Year Change | 33.61% |
| 3 Year Change | 30.76% |
| 5 Year Change | 62.58% |
| Change since IPO | 75.36% |
Recent News & Updates
JiangSu WuZhong Pharmaceutical Development (SHSE:600200) Is Making Moderate Use Of Debt
Jun 06
Many Still Looking Away From JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHSE:600200)
Mar 12Shareholder Returns
| 600200 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 1.8% | -1.1% | 0.06% |
| 1Y | 33.6% | -12.5% | -16.1% |
Return vs Industry: 600200 exceeded the CN Pharmaceuticals industry which returned -12.5% over the past year.
Return vs Market: 600200 exceeded the CN Market which returned -16.1% over the past year.
Price Volatility
| 600200 volatility | |
|---|---|
| 600200 Average Weekly Movement | 9.5% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in CN Market | 10.2% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 600200's share price has been volatile over the past 3 months.
Volatility Over Time: 600200's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 1,050 | Qunshan Qian | www.600200.com |
JiangSu WuZhong Pharmaceutical Development Co., Ltd. engages in pharmaceutical, medical cosmetology, investment, and other industries in China and internationally. It provides genetic and chemical drugs in the fields of anti-virus, anti infection, immune regulation, anti-tumor, digestive system, cardiovascular, etc.; and modern traditional Chinese medicine.
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Fundamentals Summary
| 600200 fundamental statistics | |
|---|---|
| Market cap | CN¥6.92b |
| Earnings (TTM) | -CN¥95.04m |
| Revenue (TTM) | CN¥2.33b |
3.0x
P/S Ratio-72.8x
P/E RatioIs 600200 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600200 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.33b |
| Cost of Revenue | CN¥1.80b |
| Gross Profit | CN¥535.31m |
| Other Expenses | CN¥630.35m |
| Earnings | -CN¥95.04m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.13 |
| Gross Margin | 22.96% |
| Net Profit Margin | -4.08% |
| Debt/Equity Ratio | 101.8% |
How did 600200 perform over the long term?
See historical performance and comparison